Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Motrem by Inotrem for Septic Shock: Likelihood of Approval
Motrem is under clinical development by Inotrem and currently in Phase II for Septic Shock. According to GlobalData, Phase II...